Professor and Dean Kiyoshi Kita

Speciality / Research theme / Keywords
Tropical Medicine, Molecular Parasitology, Biochemistry
Masters ProgrammeDoctoral Programme


PhD (Pharmacy), Pharmacist

Personal/work Web page addresses



I was educated at Department of Biological Sciences, The University of Tokyo, and gradated in 1980. I joined Department of Biological Sciences, The University of Tokyo as assistant professor (1980 – 1983), and moved to Department of Parasitology, Juntendo University, School of Medicine (1983). Later, I was promoted to lecturer (1987-1990). Then, promoted to associate professor of Department of Parasitology, The Institute of Medical Science, The University of Tokyo (1991-1998). In 1998, I was appointed as Professor Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo and retired in 2016. In 2015, I was appointed as Dean of TMGH by cross-appointment system between The University of Tokyo and Nagasaki University.


Giving lectures (Biochemistry of metabolism, Drug development and Molecular Parasitology) in Nagasaki University and other Universities.


Biochemistry of metabolism of pathogens and drug development.

The country/countries where you work currently

Japan, Central and South America, Southeast Asia, Africa, USA and Europe.

Five MOST IMPORTANT/INTERESTING recent publications

  1. 5-aminolevulinic acid antiviral efficacy against SARS-CoV-2 Omicron Variant in vitro  Ngwe Tun, M.M.,Sakura,T.,Sakurai,Y.,Kurosaki,Y.,Inaoka,D.K, Shioda,N,. Smith,C.,Yasuda, J.,Morita,K.,Kita,K.(2022) Tropical Medicine and Health.In Press
  2. Antiviral activity of 5-aminolevulinic acid against variants of severe acute res-piratory syndrome coronavirus 2.Ngwe Tun, M.M.,Sakura, T.,Sakurai,Y.,Kurosaki,Y.,Inaoka,D. K.,Shioda,N.,Yasuda,J.Kita,K.,Morita,K.(2022) Trop Med Health.50,1,6 doi.org/10.1186/s41182-021-00397-x
  3. Malaria Parasites Hijack Host Receptors From Exosomes to Capture Lipopro-teins. Iso-O,N.,Komatsuya,K.,Tokumasu,F.,Isoo,N.,Ishigaki,T.,Yasui,H.,Yotsuyanagi,H., Hara,M.,Kita.K.(2021) Front Cell Dev Biol. 9, 749153 doi.org/10.3389/fcell.2021.749153
  4.  In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice. Enkai,S.,Kouguchi,H.,Inaoka,D.K.,Irie,T.,Yagi,K., Kita,K.(2021) Eur. J. Clin. Microbiol. Infect. Dis.,40,9 1815-1820 doi:10.1007/s10096-021-04230-5
  5. 5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro. Sakurai, Y., Ngwe Tun, M.M.,Kurosaki,Y.,Sakura,T.,Inaoka,D.K., Fujine,K., Kita,K.,Morita,K.,Yasuda,J.(2021)Biochem.Biophys.Res.Commun.,545,203-207. doi:10.1016/j.bbrc.2021.01.091


Contribution from basic research in Japan to the health and wellfare of the people in the world.